Syndactyly type 8

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2498OMIM:309630Q70.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Syndactyly type 8, also known as metacarpal 4-5 fusion (MF4), is a rare congenital limb malformation characterized by fusion (synostosis) of the fourth and fifth metacarpal bones in the hands. This condition is present at birth and primarily affects the skeletal structure of the hands. Affected individuals typically have shortened fourth and fifth fingers (brachydactyly) due to the bony fusion of the metacarpal bones, which may limit hand function and grip to varying degrees. The fusion is typically bilateral, affecting both hands symmetrically. The condition is inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene from one parent is sufficient to cause the disorder. Syndactyly type 8 has been linked to mutations in the FGF16 gene on the X chromosome in some families, though the genetic basis may be heterogeneous. Unlike many other forms of syndactyly that involve soft tissue webbing between the fingers, this type is distinguished by its bony fusion of the metacarpal bones rather than cutaneous or osseous fusion of the digits themselves. There is no specific cure for syndactyly type 8. Management is primarily supportive and may include orthopedic evaluation and, in some cases, surgical intervention to improve hand function if the fusion significantly impairs daily activities. Occupational therapy may also be beneficial. The condition is generally non-progressive, and many affected individuals maintain adequate hand function throughout life. Genetic counseling is recommended for affected families to discuss recurrence risks and inheritance patterns.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Syndactyly type 8.

View clinical trials →

No actively recruiting trials found for Syndactyly type 8 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Syndactyly type 8 community →

No specialists are currently listed for Syndactyly type 8.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Syndactyly type 8.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Syndactyly type 8Forum →

No community posts yet. Be the first to share your experience with Syndactyly type 8.

Start the conversation →

Latest news about Syndactyly type 8

No recent news articles for Syndactyly type 8.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Syndactyly type 8

What is Syndactyly type 8?

Syndactyly type 8, also known as metacarpal 4-5 fusion (MF4), is a rare congenital limb malformation characterized by fusion (synostosis) of the fourth and fifth metacarpal bones in the hands. This condition is present at birth and primarily affects the skeletal structure of the hands. Affected individuals typically have shortened fourth and fifth fingers (brachydactyly) due to the bony fusion of the metacarpal bones, which may limit hand function and grip to varying degrees. The fusion is typically bilateral, affecting both hands symmetrically. The condition is inherited in an autosomal domi

How is Syndactyly type 8 inherited?

Syndactyly type 8 follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Syndactyly type 8 typically begin?

Typical onset of Syndactyly type 8 is neonatal. Age of onset can vary across affected individuals.